NCT05992324 A Validation Study to Evaluate the Performance of Caption Health Lung Guidance and Interpretation
| NCT ID | NCT05992324 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Caption Health, Inc. |
| Condition | Shortness of Breath |
| Study Type | INTERVENTIONAL |
| Enrollment | 220 participants |
| Start Date | 2023-07-17 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 220 participants in total. It began in 2023-07-17 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to assess the efficacy of Caption LungAI.
Eligibility Criteria
Inclusion Criteria: * Patients over the age of 18 * Patients presenting to the hospital or outpatient setting with shortness of breath and suspected B-lines. Exclusion Criteria: * Patients in extremis/in whom a research lung ultrasound would not normally be performed due to other priorities
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05992324 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Shortness of Breath. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05992324 currently recruiting?
Yes, NCT05992324 is actively recruiting participants. Contact the research team at angeline.trinidad@gehealthcare.com for enrollment information.
Where is the NCT05992324 trial being conducted?
This trial is being conducted at New Haven, United States, Chicago, United States, Chicago, United States, Greensboro, United States.
Who is sponsoring the NCT05992324 clinical trial?
NCT05992324 is sponsored by Caption Health, Inc.. The trial plans to enroll 220 participants.